Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Capricor Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 32 | 34 | +2 |
| Shares | 2.62M | 5.54M | +2.91M (+111.0%) |
| Value | $12.5M | $18.9M | +$6.39M (+50.9%) |
New holders (5)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 2,789,699 | $9.54M | 0.54% |
| Citigroup Inc | 61,591 | $210.6K | 0.00% |
| Millennium Management LLC | 44,788 | $153.2K | 0.00% |
| Qube Research & Technologies Ltd | 5,629 | $19.3K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 1,500 | $5.13K | 0.00% |
Sold out (3)
Institutions that held Capricor Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 13,260 | $63.4K |
| Belvedere Trading LLC | 8,053 | $38.5K |
| Roffman Miller Associates Inc | 500 | $2.39K |